TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
6 hedge funds and large institutions have $380K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
83% more capital invested
Capital invested by funds: $207K → $380K (+$173K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$408K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$77.1K |
| 3 |
Renaissance Technologies
New York
|
+$70.6K |
| 4 |
VF
Virtu Financial
New York
|
+$12.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$6.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFG
Steward Financial Group
Colleyville,
Texas
|
-$3K |
| 2 |
Morgan Stanley
New York
|
-$32 |
TCBP Hedge Fund Activity: Q2 2023 in Review
6 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q2 2023, worth a combined $380K — up 83% from $207K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TCBP positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, adding an estimated $408K. The largest seller was Steward Financial Group, exiting entirely with an estimated $3K sold.
- 6 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q2 2023, up from 3 in Q1 2023.
- Funds reported $380K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q2 2023, up 83% quarter-over-quarter.
- 4 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q2 2023 and 1 closed out, a net change of +3 holders.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q2 2023 was Armistice Capital, an estimated $408K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q2 2023 was Steward Financial Group, an estimated $3K sold.
Based on aggregated 13F filings for Q2 2023.